| Factor Information | |
|---|---|
| Data ID | 2911 |
| Factor | serum levels of VEGF in C-CHD patients |
| Description | N/A |
| Biomarker | YES |
| Classification | E2 (physiological factor - biochemical index) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | angiogenic factors in children with CHD |
| p Value | <0.001 |
| Conclusion | Significantly higher mean serum levels of the studied bioindices were observed in patients with CHD having SpO2 % less than 90% than those with SpO2 % more than 90% |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 639 |
| CHD Type | isolated CHD |
| CHD Subtype | TOF/TGA/DORV/VSD/PS/PDA/ASD |
| Reference | |
|---|---|
| PMID | 20406482 |
| Year | 2010 |
| Title | Angiogenic biomarkers in children with congenital heart disease: possible implications |
| Sample | ||
|---|---|---|
| Population | children | |
| Source | patients' data | |
| Region | Assiut, Eygpt | |
| Method | t-test | |
| Race | Eygptian | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | C-CHD SpO2 >90%(Treatment) | C-CHD SpO2 <90%(Control) |
| Number | N/A | N/A |
| Age | N/A | N/A |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 206±39pg/ml(C-CHD SpO2 >90%) | 582±98pg/ml(C-CHD SpO2 <90% |
